Frequently Asked Questions

1. What is the CANCION^® System?
2. Is the CANCION^® System available to purchase?
3. How much does the CANCION^® System cost?
4. Is ORQIS^® Medical currently seeking distribution partners?
5. Is ORQIS^® Medical publicly traded? What is the ORQIS Medical ticker symbol?
6. How can I purchase stock in ORQIS^® Medical?
7. What is the MOMENTUM Clinical Trial?
8. What is acutely decompensated congestive heart failure (CHF)?
9. Who can participate in the MOMENTUM Clinical Trial?
10. Where can I learn more about the MOMENTUM Trial?
11. Can I get copies of product support materials?

Q: What is the CANCION^® System?
A: The CANCION^® System is a proprietary investigational medical device that maintains continuous blood flow in the descending aorta. The CANCION^® System is being investigated in the MOMENTUM Trial for its ability to treat patients with acutely decompensated heart failure.

Q: Is the CANCION^® System available to purchase?
A: Within the United States the CANCION^® System is being clinically evaluated in a controlled clinical trial — the MOMENTUM Trial — and is not available for purchase.

Q: How much does the CANCION^® System cost?
A: Within the United States the CANCION^® System is being clinically evaluated in a controlled clinical trial — the MOMENTUM Trial — and is not available for purchase.

Q: Is ORQIS^® Medical currently seeking distribution partners?
A: Within the US, ORQIS^® Medical is focused on successfully completing the MOMENTUM Trial and is not seeking distribution partners. ORQIS^® International is exploring limited distribution relationships. Please contact ORQIS^® International directly for additional information.

Q: Is ORQIS^® Medical publicly traded? What is the ORQIS^® Medical ticker symbol?
A: ORQIS^® Medical is not publicly traded and so has no ticker symbol.

Q: How can I purchase stock in ORQIS^® Medical?
A: ORQIS^® Medical is a privately held company; its stock is not available to the general public.

Q: What is the MOMENTUM Trial?
A: MOMENTUM stands for Multicenter Trial of the ORQIS^® Medical CRS™ cardiac recovery system for the ENhanced Treatment of Heart Failure, Unresponsive to Medical Therapy. This clinical trial is evaluating the use of a device for the treatment of acutely decompensated congestive heart failure (AD-CHF).

Q: What is acutely decompensated congestive heart failure (AD-CHF)?
A: A sudden worsening of congestive heart failure (CHF), often requiring hospitalization.

Q: Who can participate in the MOMENTUM Clinical Trial?
A: Chronic congestive heart failure patients with acute decompensation who poorly respond to medical therapy may be eligible for participation in the trial.

Q: Where can I learn more about the MOMENTUM Trial?
A: To learn more about the MOMENTUM Trial, you should visit www.MomentumTrial.com or talk to your cardiologist.

Q: Can I get copies of product support materials?
A: Product support materials are available to active participants in the MOMENTUM Trial by contacting their ORQIS Medical Clinical Specialist or by going online to the Trial Participants section of the ORQIS website. If you are a medical professional at a participating MOMENTUM Trial site and having trouble accessing the protected areas of that section, please notify the ORQIS^® Medical Webmaster at webmaster@orqis.com.